Bayer Aktiengesellschaft

Bayer Intellectual Property Gmbh

The Hong Kong University of Science and Technology

Bayer Animal Health Gmbh

Lanxess Deutschland Gmbh

Gisela Greif

Arnd Voerste

Richard K Haynes

Gabriele Schmuck

William Wai-Lun Lam

Ho-Wai Chan

Hing-Wo Tsang

Man-Ki Cheung

Folker Lieb

Achim Harder

Albrecht Marhold

Bernd Baasner

Axel Haberkorn

Iris Heep

Carl Fedtke

Robrecht Froyman

Thomas Bach

Hans-Christian Mundt

Gabriele Petry

Eva-Maria Kruedewagen

Ralf Hosse

Jürgen Krücken

Frank Wunderlich

The present invention relates to the use of triazinones such as triazinediones and triazinetriones for triazinetriones for the preparation of compositions for treating animals, in particular treating animals prophylactically, against parasitic protozoans, and to these compositions.

Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans

The present invention relates to the use of nifurtimox for the treatment of diseases caused by trichomonads, such as, for example, histomoniasis, in particular in turkeys.

Controlling diseases caused by trichomonadida

The present invention relates to the use of nifurtimox for the treatment of giardiosis, in particular in dogs and cats.

Controlling giardiosis

The present invention relates to the use of specific derivatives of triazinetriones for controlling coccidioses in livestock, especially pigs.

Use of triazinetrione sulfones for combating coccidiosis

The invention relates to a novel oocyst sporocyst protein (EtOs22) belonging to the parasite of the speciesand to the polynucleotide encoding this protein, to vectors which contain this polynucleotide, to cells which are transformed with these vectors, to antibodies which are directed against the protein, to vaccines which comprise the polynucleotide, the protein, or fragments thereof, the abovementioned vectors or antibodies directed against the protein, and to the use of polynucleotide or of polypeptide for finding active compounds for treating an infection withand active compounds which are suitable for the therapy of an infection with

Use of a novel eimeria gene and corresponding protein

This invention relates to the use of certain C-10 substituted derivatives of artemisinin of general formula (I) in the treatment and/or prophylaxis of diseases caused by infection with a parasite, certain novel C-10 substituted derivatives of artemisinin, processes for their preparation and pharmaceutical compositions containing such C-10 substituted derivatives. The compounds are particularly effective in the treatment of malaria, neosporosis and coccidiosis. 

Antiparasitic artemisinin derivatives (endoperoxides)

This invention relates to the use of certain C-10 substituted derivatives of artemisinin of general formula (I) in the treatment and/or prophylaxis of diseases caused by infection with a parasite, certain novel C-10 substitued derivatives of artemisinin, processes for their preparation and pharmaceutical compositions containing such C-10 substituted derivatives. The compounds are particularly effective in the treatment of malaria, neosporosis and coccidiosis. 

This invention relates to the use of certain C-10 substituted derivatives of artemisinin of general formula (I) in the treatment and/or prophylaxis of diseases caused by infection with a parasite, certain novel C-10 substituted deriviatives of artemisinin, processes for their preparation and pharmaceutical compositions containing such C-10 substituted derivatives. The compounds are particularly effective in the treatment of malaria, neosporosis and coccidiosis.

Compositions for controlling diseases caused by protozoans of the genus Neospora, which are characterized in that they comprise one or more active compounds which inhibit the microtubulin system of plants.

Agents for combating Neospora spec

Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas

Growing community of inventors

Remagen, Germany

Gisela Greif